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Preliminary results of subintimal angioplasty for
limb salvage in lower extremities with severe
chronic ischemia and limb-threatening ischemia
Stuart I. Myers, MD, FACS,a Daniel J. Myers,a Anwar Ahmend, MS,b
and Viswanathan Ramakrishnan, PhD,b Richmond, Va
Objective: This study examined the hypothesis that superficial femoral artery (SFA) subintimal angioplasty ( SI-PTA) can
maintain limb salvage with minimal complications in patients with symptomatic occlusive arterial disease.
Methods: From March 1, 2004, until April 28, 2006, 78 patients with rest pain (62.2%), gangrene (25.6%), or severe
progressive claudication (12.2%) were treated consecutively with 82 SFA SI-PTAs (4 bilateral). The mean age was 59 
1.2 years, and 21 (27%) of the patients were female. All patients were treated in the operating room under local anesthesia
by using fluoroscopic guidance, and the percentage SFA that was occluded was measured during the diagnostic portion
of the procedure. Selective stent placement was performed after successful recanalization of the occluded arterial
segments. Patients were treated with chronic aspirin and clopidogrel bisulfate for 3 months and followed up at 30 days
and then every 3 months with physical examination and arterial duplex scan.
Results: Of the 82 SFA SI-PTA attempts, 76 (92%) were initially successful, with an increase in the ankle-brachial index
from 0.46  0.02 to 0.88  0.01 (P < .001). Five of the six patients with a failed SFA SI-PTA were female, two of the
six had had previous bypass attempts, and one of the six had had a previous SFA SI-PTA attempt by another physician.
Forty-nine (64%) of the 76 initially successful SFA SI-PTAs required placement of a stent, and 43 (56.5%) of the
successful 76 SFA SI-PTAs required additional PTA of 1 or more arterial segments. The group treated with a successful
SFA SI-PTA had 42.5%  3.5% SFA occlusion, compared with 82%  10% (P < .05) in the group with a failed attempt
at SFA SI-PTA. Two of the six patients with initial SI-PTA failure underwent leg amputation within 30 days, three were
treated with successful leg bypass surgery, and one was lost to follow-up. Of the 76 successful SFA SI-PTAs, 5 (6.5%)
failed within 90 days, and the patients were treated successfully with leg bypass surgery. Of the 71 limbs with patent
SI-PTAs at 90 days, 68 have remained patent with a mean follow-up 10.4  0.7 months (range, 2-24 months). Three of
the 71 SFA SI-PTAs failed between 4 and 7 months (mean, 5 0.7 months): 1 patient was treated with successful bypass
surgery, 1 patient is currently considering further intervention, and 1 patient was treated with amputation. Ten (14%) of
the 71 successful SFA SI-PTAs required limited PTA for asymptomatic restenosis, as identified by the arterial duplex scan
(7.4  1.4 months; range, 2-16 months). There were no perioperative deaths, and three patients have died during
follow-up with patent SFA SI-PTAs (9.3  1.4 months).
Conclusions: These data suggest that SFA SI-PTA can be successfully used for limb salvage with minimal morbidity and
mortality in a group of patients with severe lower extremity occlusive vascular disease. ( J Vasc Surg 2006;44:1239-46.)The technique of subintimal angioplasty (SI-PTA) for
the treatment of occluded femoropopliteal arteries was first
developed by Bolia et al1 in 1987 and was first reported in
1989. These authors later reported that SI-PTA can be
applied to the tibial arteries with very good success.2,3 Over
the ensuing 19 years, a small number of centers in Europe
and North America have reported their results, with pri-
mary success rates 80% to 90% and limb salvage rates
consistently in the 80% to 90% range.4-20 Despite the
publication of Lipsitz et al14 in 2003, there have been few
publications from North American vascular centers.15-17
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skepticism of the procedure or the fact that it may require a
steep learning curve.
For this study, SI-PTA was applied to a population of
patients who presented with severe critical limb ischemia
and occlusive disease of the superficial femoral artery (SFA).
This study examined the hypothesis that lower extremity
SFA SI-PTA can maintain limb salvage with minimal mor-
bidity and mortality in patients with severe lower extremity
chronic ischemia and limb-threatening ischemia.
METHODS
FromMarch 1, 2004, until April 28, 2006, we prospec-
tively evaluated 122 consecutive patients who presented
with 126 lower extremities with severe chronic ischemia at
the McGuire VA Hospital or Medical College of Virginia
Hospital. Eighteen patients with SFA origin occlusions
were treated with femoral-distal bypasses and are not in-
cluded in this article. Seventy-eight patients (82%) with
severe chronic ischemia of 82 limbs and SFA occlusions
(82% of limbs treated with SFA occlusions) with at least 0.5
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with SFA SI-PTA. One patient had a occlusion of the SFA at
the origin and was treated with SFA SI-PTA (Figs 1 and 2). All
82 limbs (78 patients) had a patent SFA or popliteal artery
Fig 1. Subintimal angioplasty of a flush superficial fe
common femoral artery approach. Preintervention angio
reconstituted popliteal artery, just above the knee joint (
wire loop (C and D). The wire has re-entered the poplit
expansion: nonexpanded (E) and after balloon expansiodistal to the occluded SFA segment that we consideredadequate to permit re-entry of the wire and catheter. Twenty-
six of the 122 patients evaluated for severe distal leg chronic
ischemia had SFA stenoses and were excluded from this
study (all were treated with successful endovascular recon-
l artery (SFA) occlusion performed via a contralateral
of the SFA origin (A). Preintervention angiogram of the
itiation of the subintimal dissection with creation of the
tery lumen with the angioplasty balloon catheter before
.mora
gram
B). In
eal arstructions).
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 6 Myers et al 1241All 82 SFA SI-PTAs were performed in the operating
room with a C arm (OEC, 9800 Plus; GE Healthcare, Salt
Lake City, UT) with patients under local anesthesia. All
patients who presented with a serum creatinine level greater
than 1.1 mg/dL were treated with the sodium bicarbonate
Fig 2. Subintimal angioplasty of a flush superficial fe
common femoral artery approach. The angioplasty balloo
(A-C). Completion angiogram showing patent SFA, pop
arteries (D-F).protocol, as previously described.21 The arterial occlusionswere approached either by an antegrade common femoral
artery puncture or by a contralateral common femoral
artery puncture. When a contralateral femoral artery punc-
ture was used, a 45-cm 6F sheath was placed over the aortic
bifurcation. One technical modification for going up and
l artery (SFA) occlusion performed via a contralateral
anded toward the origin of SFA in an ascending manner
, tibial perineal trunk, posterior tibial, and anterior tibialmora
n exp
litealover difficult aortic bifurcations was the use of a guiding
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success. Before each SFA SI-PTA attempt, the percentage
of SFA occluded or involved with a stenosis greater than
50% was recorded during the diagnostic portion of the
arteriogram. The authors believed this to be a more accu-
rate assessment of the true length of SFA involved with
occlusion or severe stenosis, because measuring the length
of disease segments in centimeters would reflect a different
percentage of the SFA involved when comparing patients
with different limb lengths. After the diagnostic portion of
the arteriogram, a subintimal dissection plane was created
with an angled floppy hydrophilic wire (Aqwire, hydro-
philic .035 standard body, EV3, Minneapolis, Minn;
Terumo hydrophilic .035 angled floppy Glidewire, Boston
Scientific, Natick, Mass) supported by a 5F or 4F angled
catheter. Re-entry into the true lumen below the arterial
occlusion was confirmed by angiography. The recanalized
segment was then subjected to balloon insufflation, and the
need for stent placement was determined by the results of
the completion arteriogram. A stent was placed if there was
significant recoil of the lesion or residual stenosis greater
than 30% or for intimal dissections causing a flow-limiting
lesion or thought to be a high risk for progression to a
flow-limiting lesion. The stents were all self-expanding bare
stents. The length of the stent (or stents) was determined
by the length of artery that needed to be treated. The senior
author used long stents (100-120 mm) when the segment
of SFA requiring a stent was of a similar length. The site of
re-entry of the subintimal dissection was purposely chosen
both to be below the arterial occlusion and to avoid using
an arterial segment that could be used for future bypass
grafting (Figs 1 and 2).
SI-PTA has been previously described,1-20 and its de-
scription will not be repeated here. Significant arterial ste-
noses proximal or distal to the recanalized subintimal seg-
ment were treated concurrently with balloon PTA with or
without stent placement.
All patients were continued on chronic aspirin treat-
ment, and clopidogrel bisulfate was given for 3 months
after the SFA SI-PTA. The patients were evaluated with
physical examination, segmental limb pressures, pulse vol-
ume recordings, and arterial duplex scanning before the
procedure, before discharge, 30 days after discharge, and
every 3 months thereafter.
Risk factors, demographics, initial technical success,
short-term and long-term morbidity and mortality, recur-
rent disease, and short-term patency were evaluated with
the reporting standards developed by the Joint Council of
the Society for Vascular Surgery and the North American
Chapter of the International Society for Cardiovascular
Surgery.22 Patency of the arterial SI-PTAs was defined as
antegrade flow without significant stenoses (30%). Le-
sions were considered to be recurrences when the stenosis
was 50% (ratio of the peak systolic velocity of the involved
SFA compared with the proximal normal segment 2, as
identified by the duplex scan). Long-term assisted primary
patency and limb survival were calculated by using Kaplan-
Meier curves. Comparisons between the survival plots weremade by using a log-rank statistic for the 76 SFA SI-PTAs
that were initially successful. The primary assisted patency
combines patency after the initial SFA SI-PTA and treat-
ment of recurrent lesions with additional endovascular
interventions.
RESULTS
Demographic data. FromMarch 2004 to April 2006,
78 patients with 82 limbs with severe chronic ischemia and
SFA occlusions were treated consecutively with SFA SI-
PTA. The 57 men (73%) and 21 women (27%) ranged in
age from 42 to 88 years (mean, 59.4 1.2 years). Fifty-one
limbs (62.2%) were treated for rest pain (category 4), 21
limbs (25.6%) were treated for nonhealing ulcers or gan-
grene (category 5), and 10 limbs (12.2%) were treated with
severe progressive claudication (category 3). A large per-
centage of the patients had multiple significant medical
comorbidities, which are listed in Table I. It should be
noted that 15 of the 78 patients presented with a serum
creatinine level greater than 1.4 mg/dL (upper limits of
normal in our laboratory).
Technical outcomes. Seventy-two patients (92.6%)
underwent 76 successful SFA SI-PTAs, whereas 6 (7.4%)
attempts at SFA SI-PTA failed (Table II). The technical
reasons for failure to perform SFA SI-PTA were inability to
pass a wire through the SFA occlusion in five patients and
inability to follow successful wire placement with catheter
advancement in one patient. Five of the six patients who did
not have successful SFA SI-PTA were female. One of these
female patients had two previous leg bypasses, and one had
an unsuccessful attempt at SFA SI-PTA by another physi-
Table I. Risk factors for the patient population
Variable Data
Tobacco use 94.8%
Hypertension 75.6%
Lipid abnormalities 65.0%
Diabetes mellitus 63.0%
Coronary artery disease 46.0%
Mean serum creatinine 1.37 mg/dL
Chronic obstructive pulmonary disease 14.6%
History of stroke 10.0%
Drug/alcohol abuse 10.0%
Table II. Outcome of SFA SI-PTA attempts (90 days)
Variable Data
Total No. limbs at risk 82
Successful initial SFA SI-PTA 76 (92.6%)
Unsuccessful initial SFA SI-PTA 6 (7.4%)
Failure of SFA SI-PTA 90 d 5 (6.1%)
Patent SFA SI-PTA 90 d 71 (86.6%)
Total amputations 90 d 2 (2.4%)
Bypass 90 d 8 (9.7%)
Lost to follow-up 90 d 1 (1.2%)
Superficial femoral artery subintimal angioplasty.cian. Of the six patients with unsuccessful SFA SI-PTA,
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to follow-up, and two required below-knee amputation
because they were referred from other institutions after
attempts at unsuccessful bypass surgery. Five patients with a
successful SFA SI-PTA experienced treatment failure
within 90 days and were termed the open/close group (see
below). Two of these five patients did not take the sug-
gested antiplatelet agents. All were treated successfully with
leg bypass surgery. Table III provides a summary of the
total number of patients in whom SFA-SI-PTA failed
within 90 days of the procedure.
Forty-three (56%) of the 76 successful SFA SI-PTAs
required a stent. Of the 11 SFA SI-PTAs that failed either
initially or by 90 days after the procedure, 7 were treated
with a stent.
Forty-three (56%) of the 76 successful SFA SI-PTAs re-
quired aPTAor SI-PTAof additional arterial segments. These
included the iliac artery (n  10), proximal SFA (n  4),
popliteal artery (n 16), tibial/peroneal trunk (n 12), and
tibial arteries (n 20).
Table III details the percentage occlusion and percent-
age diseased SFAs for all patients, for those with initial
treatment failures, for those who had treatment failures
within 90 days, and for those who had recurrence. The
percentage occlusion of SFA in the initial failure group and
in the group who had failure by 90 days was significantly
higher than the percentage occlusion in the group with
initial SFA SI-PTA success (P .01). Only the initial failure
group had a significant combined percentage occlusion and
severe stenosis compared with the initial success group.
Although this finding would suggest that SFA SI-PTA has
a higher success rate in SFAs with less percentage occlusion,
one must be cautious, because 15 limbs with percentage
occlusions ranging from 75% to 90% underwent successful
SFA SI-PTA. It is interesting to note that the percentage
occlusion in the recurrence group was less than the percent-
age occlusion in the initial successful SFA SI-PTA group.
Table III. Indications for intervention and short-term and
Variable
Group 1 (76 successful initial SFA SI-PTAs)
Group 2 (6 initial SFA SI-PTA failures)
Group 3 (5 occlusions after initial technical success;  90 d)
Group 4 (10 recurrent lesions)
SFA, Superficial femoral artery; SI-PTA, subintimal angioplasty.
*P  .05 vs group 1 by the Student t test.
Table IV. Indications for intervention and short-term and
Variable (seve
Initial technical failure
Occlusion after initial technical success (90 d)
TotalTable IV demonstrates that 10 of the 11 patients who hadinitial or long-term failure of the SFA SI-PTA presented
with either category 4 or category 5 indications for inter-
vention. These findings suggest that factors other than the
length of SFA occlusion contribute to the initial and short-
term success of the SFA SI-PTA.
Clinical outcomes. All patients with a successful SFA
SI-PTA underwent duplex imaging of the treated arteries
and measurement of ankle-brachial indexes (ABI). For the
group of successful SFA SI-PTAs, the duplex scans showed
patent SFA SI-PTAs and the other arteries treated with PTA
and SI-PTA. The ABI was measured in patients who had
compressible vessels (n 76) and increased from0.45 0.02
to 0.86  0.02 after the procedure. The patients with
successful SFA SI-PTAs experienced resolution of claudica-
tion and either resolution or a marked improvement of rest
pain. The patients who presented with ulcers and areas of
gangrene have responded to aggressive surgical debride-
ment and wound care, and have all healed.
There were three late failures after successful SI-PTA.
One patient who had two previous attempts at limb salvage
with bypass surgery had an occluded SFA SI-PTA at
7 months and refused further reconstruction. Two other
patients had occluded SFA SI-PTAs at 4 months and are
being closely followed up with severe but stable claudica-
tion and will be offered open surgical bypass options in the
near future. One patient was lost to follow-up 5 months
after successful SFA SI-PTA.
The 71 patients who had successful SFA SI-PTAs that
were patent 90 days or more have a cumulative patency rate
of 86% with a mean follow-up of 10.0 0.76 months. Ten
(14%) of the 71 SFA SI-PTAs that were patent for longer
than 90 days have required a limited PTA for asymptomatic
stenosis, which was identified during routine outpatient
follow-up duplex scanning. None of the 10 patients had a
decrease in ABI despite the demonstration of a 50% or
more recurrence on duplex scan. Asymptomatic recurrent
stenoses occurred at 7.4  1.4 months (range, 2-16
g-term failures
FA occluded % SFA with stenosis % Total SFA disease
.5%  5.5% 31.5%  2.3% 77.2%  4.6%
2%  10%* 17%  11% 99%  0.2%*
7%  12%* 15%  7% 92%  5.8%
.4%  12%* 40%  6.4% 63.4%  7%
g-term failures
gory 3
udication)
Category 4
(rest pain)
Category 5
(ulcer/gangrene)
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0 4 1
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re clamonths). All 10 of these patients have continued to have
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shows the pattern for primary assisted patency of the ini-
tially successful SFA SI-PTAs grouped by sex. With the
log-rank test, a P value of .0151 indicates that there is a
decreased primary assisted patency in female patients com-
pared with male patients. Figure 4 shows that the aggressive
use of arterial bypass for failed SI-PTAs and the treatment
of recurrent lesions by endovascular methods resulted in a
excellent limb salvage rates for all patients, because no
significant differences were found betweenmale and female
patients.
Complications. One patient with known nonrecon-
structible three-vessel coronary artery disease developed
symptomatic angina the night after successful SFA SI-PTA,
but it responded quickly to medical treatment. One patient
had a femoral artery sheath accidentally pulled during
Fig 3. Kaplan-Meier survival comparing the patency of initially
successful superficial femoral artery (SFA) subintimal angioplasties
between male (solid line) and female (dashed line) patients. With
the log-rank test, a P value of .0151 indicates decreased survival of
the patent SFA in female patients. M, Male; F, female.
Fig 4. Kaplan-Meier analysis for limb salvage for all patients after
initially successful superficial femoral artery subintimal angioplas-
ties.transfer from a stretcher and required surgical repair ofthe femoral artery under local anesthesia. There were no
periprocedural myocardial infarctions, cerebrovascular ac-
cidents, renal failures, or pulmonary complications. There
were no instances of pseudoaneurysm of the femoral artery
puncture site, and there was no evidence of distal emboli-
zation after SFA SI-PTA.
Mortality. During follow-up, three patients died with
patent SFA SI-PTAs and intact limbs. Two patients suc-
cumbed to known cancer at 7 and 9 months, and one
patient died of an acute myocardial infarction at 12 months
with a patent SFA SI-PTA reconstruction. One patient was
diagnosed with cancer of the pancreas 13 months after
successful SFA SI-PTA but continues to do well.
DISCUSSION
As described previously, SI-PTA is not new; it was first
performed in 1987 and reported in 1989 by Bolia and
colleagues1-3 for the treatment of occluded infrainguinal
arteries. The senior author learned the technique of SI-PTA
during a 13-week endovascular fellowship in which training
occurred 1 to 2 weeks per month over a 9-month period.
Thus, the senior author was in an excellent position to
evaluate SFA SI-PTA in a prospective manner to deter-
mine whether this technique can be easily learned and
rapidly applied by one who recently completed endovas-
cular training.
The initial technical success rate of 92.6% and the 90-day
technical success rate of 86.5% in this series are well within the
range of the 80% to 90% technical success rates previously
reported.1-20 The combined patency rate of 82.3% at 10.5 
0.7 months in this series is also well within the 60% to 89%
patency rates reported at 6 months’ follow-up.1-20 It should
be noted that the senior author did not attempt to perform
an SFA SI-PTA alone until after participating in 15 SI-
PTAs with experienced mentors during endovascular train-
ing. This author strongly believes that receiving advanced
endovascular training with SI-PTAs has allowed successful
performance of these procedures, with results compatible
with the data reported in the literature. Five of the six initial
failed attempts at performing SFA SI-PTA in this series
occurred within the first 10 months of the study, whereas
one of the initial failures occurred in the last 14 months of
this study. These data suggest that SFA SI-PTA, as with all
surgical and endovascular procedures, has a learning curve
and reinforce the notion that SFA SI-PTA should be per-
formed only after adequate training.
Aggressive use of the duplex scan during follow-up
helped to identify 10 patients who developed asymptom-
atic recurrences with a 50% diameter reduction. These 10
patients with asymptomatic recurrences have all been
treated successfully with limited PTAs and have maintained
patent SFA SI-PTAs on subsequent follow-up. One patient
who underwent successful SFA SI-PTA in May 2005 was
treated with a PTA for a recurrence 7 months later. This
patient continues to have a patent SFA and remains symp-
tom free 19 months after the original procedure.
As noted previously, the indications for intervention
were rest pain, nonhealing ulcers or gangrene, or severe
JOURNAL OF VASCULAR SURGERY
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series for stable intermittent claudication. Several of the
previously reported series have described performing SI-
PTAs for stable claudication and have dwelt more on the
anatomy of the treated occlusions than on the indications
for the interventions. Even though this procedure can be
performed with patients under local anesthesia with mini-
mal morbidity and mortality, the indications for SFA SI-
PTA should be the same as those used for open surgical
lower extremity bypass (rest pain, nonhealing ulcers or
gangrene, and severe progressive claudication).
The data in Table III suggest that the rate of initial SFA
SI-PTA failure correlates with the length of total occlusion,
as well as total SFA occlusion combined with total diseased
SFA. One must be cautious in interpreting these findings,
because the number of initial SFA SI-PTA failures was small
and because 15 of the successful SFA SI-PTAs (short-term
and long-term) had percentage occlusions of the SFA that
ranged from 75% to 90%. This information, as well as the
smaller percentage of SFA occlusions in the recurrence
group, would suggest that other factors, such as the char-
acter of the plaque (calcification, amount of inflammation,
and so on), may be just as important as the percentage of
SFA occluded in determining initial and long-term SFA
SI-PTA success. Lipsitz et al14 thought that the inability to
place the wire in the subintimal plane or follow a success-
fully placed wire with a catheter occurred in SFA lesions
that were extremely dense with severe calcific plaque.
Several technical modifications have been used in this
study to perform successful SFA SI-PTA in very difficult
arterial lesions. First, when using a contralateral approach
to an extremity, one must have long guide catheters and
balloon and stent catheters with long shafts to be able to
reach the contralateral below-knee arterial segments. When
using an antegrade femoral artery approach, shorter cathe-
ter shaft lengths are more appropriate. Second, when ap-
proaching arterial occlusions involving long arterial seg-
ments, the author has found that using balloon lengths of
120 mm and long stent lengths (80-120 mm) helps to
minimize the time spent during the procedure as well as to
achieve excellent technical results. Third, when it is difficult
to advance a guide catheter through the subintimal plane
over a successfully placed hydrophilic wire, one can switch
to a 3-mm/120-cm low-profile balloon and angioplasty
the plaque. This almost always allows advancement of the
balloon catheter over the wire, through the subintimal
space, and into the area of arterial re-entry.
This study did not use several other techniques de-
scribed for use in difficult SI-PTAs. Retrograde SI-PTA has
been described for flush SFA occlusions.17,23,24 A retro-
grade puncture of the popliteal artery by using duplex
ultrasonography is performed, and SFA SI-PTA is per-
formed from the distal SFA to the proximal SFA, which is
opposite the direction used for the standard approach. The
retrograde SFA SI-PTA approach has a reported patency
rate of 62% at 1 year.20 This study also did not use the
technique described by Balas et al,25 which approaches
flush occlusions of the SFA with a combination of opensurgery and endovascular techniques. The third technique
not used in this study is one that uses one of several re-entry
devices for locating and puncturing the distal “re-entry”
artery. Although these devices were not available to the
author during this study, the author believes that their use,
as well as the other techniques described previously, will
decrease the initial failure rate of SFA SI-PTA and extend its
use for all patients with flush SFA occlusions.
There are several limitations of this study. First, al-
though the study was prospective, it does not provide a
prospective comparison of SFA SI-PTA to bypass surgery.
However, the authors do not view these techniques as
competitive, but as complementary, in terms of extending
the time of total limb salvage. Second, as described previ-
ously, this series did not use the new re-entry devices or the
techniques described that use retrograde SFA SI-PTA or
open SFA-SI-PTA. It would seem logical that these devices
and techniques would help to decrease the initial failure
rate of the procedure and extend its use to more patients.
Third, the data in Figs 1 and 2 must be interpreted care-
fully, because the analysis was performed only on the 76
patients with initial SFA SI-PTA success. This statistical
approach was used to focus on the patterns of survival for
patency and limb salvage when the SFA-SI-PTA was suc-
cessfully performed.
On the basis of the results of this study and those
reported in the literature, several conclusions can be drawn.
First, SFA SI-PTA can be performed successfully with a low
complication rate and a high initial success rate and with
patients under local anesthesia. This minimally invasive
approach avoids wound complications and most likely will
reduce hospital lengths of stay because patients typically
leave the hospital the day after the procedure. The other
techniques described previously7,23-25 may help to further
increase the initial technical success rate. Second, one
should not attempt these procedures without appropriate
training and equipment. There is a learning curve to all
invasive procedures, including SFA SI-PTA. Third, as de-
scribed by Lipsitz et al,14 the indications for treating pa-
tients with SI-PTA should be the same as those used for
open bypass surgery and therefore should not include sta-
ble intermittent claudication. Fourth, SFA SI-PTA is not
viewed by the authors to take the place of open bypass
surgery, but rather to extend the time of limb salvage.
Although the short-term primary assisted patency rate and
limb salvage rates were quite good, it was clear during the
course of follow-up that an increasing number of patients
were developing either recurrent lesions or progression of
more proximal or more distal disease. Aggressive use of
duplex arterial scanning in combination with history and
physical examinations allowed treatment of recurrent le-
sions before the patency or limb salvage rates were altered.
It is our opinion that one cannot perform any endovascular
treatment of the lower extremity without an aggressive
follow-up. The long-term patency and limb salvage rates of
SFA SI-PTA are not known. However, even if one can
provide limb salvage or resolution of severe critical limb
ischemia for 1 to 2 years, the patients can still be treated
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salvage. Fifth, the use of SFA SI-PTA with its minimally
invasive approach may provide an alternative for patients
presenting with critical limb ischemia who are deemed at
high risk for open operative procedures. Sixth, the data in
Table IV suggest that lower success rates with SFA SI-PTA
may be anticipated when treating patients who present with
rest pain and gangrene as compared with patients with
severe progressive claudication.
AUTHOR CONTRIBUTIONS
Conception and design: SIM, AA, VR
Analysis and interpretation: SIM, DJM, AA, VR
Data collection: SIM, DJM
Writing the article: SIM, DJM, AA, VR
Critical revision of the article: SIM
Final approval of the article: SIM
Statistical analysis: DJM, AA, VR
Overall responsibility: SIM
REFERENCES
1. Bolia A, Brennan J, Bell PR. Recanalization of femoro-popliteal occlu-
sions: improving success rate by subintimal recanalization. Clin Radiol
1989;40:325.
2. Bolia A, Sayers RD, Thompson MM, Bell RR. Subintimal and intralu-
minal recanalization of occluded crural arteries by percutaneous balloon
angioplasty. Eur J Vasc Surg 1994;8:214-9.
3. Nydahl S, London NJ, Bolia A. Technical report: recanalization of all
three infrapopliteal arteries by subintimal angioplasty. Clin Radiol
1996;51:366-7.
4. Bolia A. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc
Surg (Torino) 2005;46:385-94.
5. Smith BM, StechmanM,GibsonM, Torrie EP,Magee TR, Galland RB.
Subintimal angioplasty for superficial femoral artery occlusion: poor
patency in critical ischaemia. Ann R Coll Surg Engl 2005;87:361-5.
6. Mousa A, Rhee JY, Trocciola SM, Dayal R, Beauford RB, Kumar N,
et al. Percutaneous endovascular treatment for chronic limb ischemia.
Ann Vasc Surg 2005;19:186-91.
7. Florenes T, Bay D, Sandbaek G, Saetre T, Jorgensen JJ, Slagsvold CE,
et al. Subintimal angioplasty in the treatment of patients with intermit-
tent claudication: long term results. Eur J Vasc Endovasc Surg 2004;
28:645-50.
8. Tartari S, Zattoni L, Rolma G, Sacco A. Subintimal angioplasty of
infrapopliteal artery occlusions in the treatment of critical limb isch-
aemia. Short-term results. Radiol Med (Torino) 2004;108:265-74.
9. Hynes N, Akhtar Y, Manning B, Aremu M, Oiakhinan K, Courtneyagement of critical limb ischemia: comparison to bypass grafting for
aortoiliac and femoropopliteal occlusive disease. J Endovasc Ther
2004;11:460-71.
10. Desgranges P, Boufi M, Lapeyre M, Tarquini G, van Laere O, Losy F,
et al. Subintimal angioplasty: feasible and durable. Eur J Vasc Endovasc
Surg 2004;28:138-41.
11. Loftus IM, Hayes PD, Bell PR. Subintimal angioplasty in lower limb
ischaemia [review]. J Cardiovasc Surg (Torino) 2004;45:217-29.
12. Yilmaz S, Sindel T, Yegin A, Luleci E. Subintimal angioplasty of long
superficial femoral artery occlusions. J Vasc Interv Radiol 2003;14:997-
1010.
13. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a
treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc
Surg 2003;25:578-82.
14. Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Cynamon J, et al.
Does subintimal angioplasty have a role in the treatment of severe lower
extremity ischemia? J Vasc Surg 2003;37:386-91.
15. Treiman GS, Treiman R, Whiting J. Results of percutaneous subintimal
angioplasty using routine stenting. J Vasc Surg 2006;43:513-9.
16. Black JH, LaMuraglia GM, Kwolek CJ, Brewster DC, Watkins MT,
Cambria RP. Contemporary results of angioplasty-based infrainguinal
percutaneous interventions. J Vasc Surg 2005;42:932-9.
17. Spinosa DJ, Leung DA, Matsumoto AH, Bissonette EA, Cage D,
Harthun NL, et al. Percutaneous intentional extraluminal recanaliza-
tion in patients with chronic critical limb ischemia. Radiology 2005;
237:744-5.
18. London NJ, Bolia A, Bell PR. Subintimal angioplasty for femoropopli-
teal artery occlusion. Lancet 1993;341:238.
19. Reekers JA, Bolia A. Percutaneous intentional extraluminal (subinti-
mal) recanalization: how to do it yourself. Eur J Radiol 1998;28:192-8.
20. McCarthy RJ, Neary W, Roobottom C, Tottle A, Ashley S. Short-term
results of femoropopliteal subintimal angioplasty. Br J Surg 2000;87:1361-5.
21. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kow-
alchuk GJ, et al. Prevention of contrast-induced nephropathy with
sodium bicarbonate: a randomized controlled trial. JAMA 2004;19:
2328-34.
22. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S,
et al. Recommended standards for reports dealing with lower extremity
ischemia: revised version. J Vasc Surg 1997;26:517-38.
23. Heenan SD, Vinnicombe SJ, Buckenham TM, Belli AM. Percutaneous
transluminal angioplasty by a retrograde subintimal transpopliteal ap-
proach. Clin Radiol 1995;50:507-8.
24. Yilmaz S, Sindel T, Ceken K, Alimoglu E, Luleci E. Subintimal recan-
alization of long superficial femoral artery occlusions through the
retrograde popliteal approach. Cardiovasc Intervent Radiol 2001;24:
154-60.
25. Balas P, Pangratis N, Ioannou N, Milas P, Klonaris C, Masouridou E.
Open subintimal angioplasty of the superficial femoral and distal arter-
ies. J Endovasc Ther 2000;7:68-71.D, et al. Subintimal angioplasty as a primary modality in the man- Submitted Jan 10, 2006; accepted Aug 9, 2006.
AVAILABILITY OF JOURNAL BACK ISSUES
As a service to our subscribers, copies of back issues of Journal of Vascular Surgery for the preceding
5 years are maintained and are available for purchase fromMosby until inventory is depleted. Please write
to Elsevier Inc., Subscription Customer Service, 6277 Sea Harbor Dr, Orlando, FL 32887, or call
800-654-2452 or 407-345-4000 for information on availability of particular issues and prices.
